MiR-150: Targeting MLL leukemia

Oncotarget

Volumn 3, Issue 11, 2012, Pages 1268-1269

  Jiang, Xi ^a   Chen, Jianjun ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CELL PROTEIN; LIN28 PROTEIN; METHIONINE; MICRORNA; MICRORNA 150; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; CANCER PROGNOSIS; CANCER RESISTANCE; CARCINOGENESIS; DOWN REGULATION; EDITORIAL; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE REPRESSION; GENE TARGETING; GENE TRANSLOCATION; GENETIC ASSOCIATION; HUMAN; LEUKEMIA; MALIGNANT TRANSFORMATION; MIXED LINKAGE LEUKEMIA GENE; ONCOGENE; POSTTRANSCRIPTIONAL GENE SILENCING;

EID: 84872797716     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.736     Document Type: Editorial

References (8)

1. Chen J, Odenike O and Rowley JD. Nat Rev Cancer. 2010; 10(1):23-36.
2. Jin S, Zhao H, Yi Y, et al. J Clin Invest. 2010; 120(2):593-606.
3. Lin CY, Loven J, Rahl PB, et al. Cell. 2012; 151(1):56-67.
4. Li L, Piloto O, Kim KT, et al. Br J Haematol. 2007; 137(1):64-75.
5. Chang TC, Zeitels LR, Hwang HW, et al. PNAS. 2009; 106(9):3384-3389.
6. Jiang X, Huang H, Li Z, et al. Cancer Cell. 2012; 22(4):524-535.
7. Fathi AT and Chen YB. Am J Blood Res. 2011; 1(2):175-189.
8. Dawson MA, Prinjha RK, Dittmann A, et al. Nature. 2011; 478(7370):529-533.